Seminars in Hematology
Volume 42, Issue 1 , Pages 15-28 , January 2005

Phenotypic and genotypic diagnosis of von Willebrand disease: A 2004 update

  • Reinhard Schneppenheim

      Affiliations

    • University Hospital Hamburg-Eppendorf, Department of Pediatric Hematology and Oncology, Hamburg, Germany
    • Corresponding Author InformationAddress correspondence to Reinhard Schneppenheim, MD, PhD, University Hospital Hamburg-Eppendorf, Department of Pediatric Hematology and Oncology, Martinistrasse 52, D-20246 Hamburg, Germany
    • ,
  • Ulrich Budde

      Affiliations

    • Lab Association Prof., Arndt and Partners, Coagulation Laboratory, Hamburg, Germany

References 

  1. Fujimura Y , Titani K , Holland LZ , Russell SR , Roberts JR , Elder JH , et al.   von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib . J Biol Chem . 1986;261:381–385
  2. Plow EF , Pierschbacher MD , Ruoslahti E , Marguerie GA , Ginsberg MH . The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets . Proc Natl Acad Sci U S A . 1985;82:8057–8061
  3. Foster PA , Fulcher CA , Marti T , Titani K , Zimmerman TS . A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor . J Biol Chem . 1987;262:8443–8446
  4. Pareti FI , Niiya K , McPherson JM , Ruggeri ZM . Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III . J Biol Chem . 1987;262:13835–13841
  5. Mohri H , Yoshioka A , Zimmerman TS , Ruggeri ZM . Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen and characterization of its three distinct functional sites . J Biol Chem . 1989;264:17361–17367
  6. Ruggeri ZM . Platelet and von Willebrand factor interactions at the vessel wall . Hamostaseologie . 2004;24:1–11
  7. Weiss HJ , Sussman II , Hoyer LW . Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand’s disease . J Clin Invest . 1977;60:390–404
  8. Fischer BE , Kramer G , Mitterer A , Grillberger L , Reiter M , Mundt W , et al.   Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII . Thromb Res . 1996;84:55–66
  9. Mayadas TN , Wagner DD . Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly . Proc Natl Acad Sci U S A . 1992;89:3531–3535
  10. Marti T , Rosselet SJ , Titani K , Walsh KA . Identification of disulfide-bridged substructures within human von Willebrand factor . Biochemistry . 1987;26:8099–8109
  11. Schneppenheim R , Brassard J , Krey S , Budde U , Kunicki TJ , Holmberg L , et al.   Defective dimerization of von Willebrand factor subunits due to a Cys→Arg mutation in type IID von Willebrand disease . Proc Natl Acad Sci U S A . 1996;93:3581–3586
  12. Schneppenheim R , Budde U , Obser T , Brassard J , Mainusch K , Ruggeri ZM , et al.   Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease . Blood . 2001;97:2059–2066
  13. Schneppenheim R , Obser T , Schneppenheim S , Mainusch K , Angerhaus D , Budde U . Von Willebrand disease type 2A with aberrant structure of individual oligomers is caused by mutations clustering in the von Willebrand factor D3 domain . Blood . 2000;96:566a; (abstr)
  14. Gaucher C , Dieval J , Mazurier C . Characterization of von Willebrand factor gene defects in two unrelated patients with type IIC von Willebrand disease . Blood . 1994;84:1024–1030
  15. Schneppenheim R , Thomas KB , Krey S , Budde U , Jessat U , Sutor AH , et al.   Identification of a candidate missense mutation in a family with von Willebrand disease type IIC . Hum Genet . 1995;95:681–686
  16. Holmberg L , Karpman D , Isaksson C , Kristoffersson AC , Lethagen S , Schneppenheim R . Ins405AsnPro mutation in the von Willebrand factor propeptide in recessive type 2A (IIC) von Willebrand’s disease . Thromb Haemost . 1998;79:718–722
  17. Allen S , Abuzenadah AM , Hinks J , Blagg JL , Gursel T , Ingerslev J , et al.   A novel von Willebrand disease-causing mutation (Arg273Trp) in the von Willebrand factor propeptide that results in defective multimerization and secretion . Blood . 2000;96:560–568
  18. Rosenberg JB , Haberichter SL , Jozwiak MA , Vokac EA , Kroner PA , Fahs SA , et al.   The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF . Blood . 2002;100:1699–1706
  19. Ruggeri ZM , Pareti FI , Mannucci PM , Ciavarella N , Zimmerman TS . Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand’s disease . N Engl J Med . 1980;302:1047–1051
  20. Casonato A , Sartori MT , Bertomoro A , Fede T , Vasoin F , Girolami A . Pregnancy-induced worsening of thrombocytopenia in a patient with type IIB von Willebrand’s disease . Blood Coagul Fibrinolysis . 1991;2:33–40
  21. Casonato A , Sartori MT , de Marco L , Girolami A . 1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type IIB von Willebrand’s disease (Shortening of bleeding time and induction of a variable pseudothrombocytopenia) . Thromb Haemost . 1900;64:117–120
  22. Donner M , Kristoffersson AC , Lenk H , Scheibel E , Dahlback B , Nilsson IM , et al.   Type IIB von Willebrand’s disease (Gene mutations and clinical presentation in nine families from Denmark, Germany and Sweden) . Br J Haematol . 1992;82:58–65
  23. Nishino M , Girma JP , Rothschild C , Fressinaud E , Meyer D . New variant of von Willebrand disease with defective binding to factor VIII . Blood . 1989;74:1591–1599
  24. von Willebrand EA . Hereditär pseudohemofili . Finska Lakaresallskapets Handlingar . 1926;672:7–112
  25. Gaucher C , Jorieux S , Mercier B , Oufkir D , Mazurier C . The “Normandy” variant of von Willebrand disease (Characterization of a point mutation in the von Willebrand factor gene) . Blood . 1991;77:1937–1941
  26. Cacheris PM , Nichols WC , Ginsburg D . Molecular characterization of a unique von Willebrand disease variant. A novel mutation affecting von Willebrand factor/factor VIII interaction . J Biol Chem . 1991;266:13499–13502
  27. Schneppenheim R , Budde U , Krey S , Drewke E , Bergmann F , Lechler E , et al.   Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1 . Thromb Haemost . 1996;76:598–602
  28. Schneppenheim R , Lenk H , Obser T , Oldenburg J , Oyen F , Schneppenheim S , et al.   Recombinant expression of mutations causing von Willebrand disease type Normandy (Characterization of a combined defect of factor VIII binding and multimerization) . Thromb Haemost . 2004;92:36–41
  29. Sadler JE  Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis . A revised classification of von Willebrand disease . Thromb Haemost . 1994;71:520–525
  30. Ribba AS , Loisel I , Lavergne JM , Juhan-Vague I , Obert B , Cherel G , et al.   Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen . Thromb Haemost . 2001;86:848–854
  31. Schneppenheim R , Obser T , Drewke E , Gross-Wieltsch U , Oyen F , Sutor AH , et al.   Isolated molecular defects of von Willebrand factor binding to collagen do not correlate with bleeding symptoms . Blood . 2001;98:165; (abstr)
  32. Mannucci PM , Lombardi R , Castaman G , Dent JA , Lattuada A , Rodeghiero F , et al.   von Willebrand disease “Vicenza” with larger-than-normal (supranormal) von Willebrand factor multimers . Blood . 1988;71:65–70
  33. Casonato A , Pontara E , Sartorello F , Cattini MG , Sartori MT , Padrini R , et al.   Reduced von Willebrand factor survival in type Vicenza von Willebrand disease . Blood . 2002;99:180–184
  34. Lenting PJ , Westein E , Terraube V , Ribba AS , Huizinga EG , Meyer D , et al.   An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation . J Biol Chem . 2004;279:12102–12109
  35. Rugggeri ZM . Classification of von Willebrand disease . In:  Verstraete M ,  Vermylen J ,  Lijnen R ,  Arnout J editor. Thrombosis and Haemostasis . Leuven, The Netherlands: Leuven University Press; 1987;p. 419–445
  36. Rodeghiero F , Castaman G . Congenital von Willebrand disease type I (Definition, phenotypes, clinical and laboratory assessment) . Baillieres Clin Haematol . 2001;14:321–335
  37. Sadler JE . Von Willebrand disease type 1 (A diagnosis in search of a disease) . Blood . 2003;101:2089–2093
  38. Rodeghiero F , Castaman GC , Tosetto A , Lattuada A , Mannucci PM . Platelet von Willebrand factor assay—Results using 2 methods for platelet lysis . Thromb Res . 1990;59:259–267
  39. Vlot AJ , Mauser Bunschoten EP , Zarkova AG , Haan E , Kruitwagen CL , Sixma JJ , et al.   The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A . Thromb Haemost . 2000;83:65–69
  40. Kinoshita S , Harrison J , Lazerson J , Abildgaard CF . A new variant of dominant type II von Willebrand’s disease with aberrant multimeric pattern of factor VIII-related antigen (type IID) . Blood . 1984;63:1369–1371
  41. Ruggeri ZM , Nilsson IM , Lombardi R , Holmberg L , Zimmerman TS . Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand’s disease (type IIC) . J Clin Invest . 1982;70:1124–1127
  42. Ledford M , Rabinowtz I , Sadler JE , et al.   New variant of von Willebrand disease type II with markedly increased levels of von Willebrand factor antigen and dominant mode of inheritance (von Willebrand disease type IIC Miami) . Blood . 1993;82:169–175
  43. Zimmerman TS , Dent JA , Ruggeri ZM , Nannini LH . Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID and IIE) . J Clin Invest . 1986;77:947–951
  44. Weiss HJ , Sussman II . A new von Willebrand variant (type I, New York) (Increased ristocetin-induced palatelet aggregation and plasma von Willebrand factor containing the full range of multimers) . Blood . 1986;68:149–156
  45. Holmberg L , Berntorp E , Donner M , Nilsson IM . von Willebrand’s disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma . Blood . 1986;68:668–672
  46. Zieger B , Budde U , Jessat U , Zimmerman R , Simon M , Katzel R , et al.   New families with von Willebrand disease type 2M (Vicenza) . Thromb Res . 1987;87:57–64
  47. Mazurier C . Von Willebrand disease masquerading as haemophilia A . Thromb Haemost . 1992;67:391–396
  48. Jorieux S , Gaucher C , Goudemand J , Mazurier C . A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind factor VIII and affects its multimerization . Blood . 1998;92:4463–4670
  49. Jorieux S , Fressinaud E , Goudemand J , Gaucher C , Meyer D , Mazurier C . Conformational changes in the D′ domain of von Willebrand factor induced by CYS25 and CYS95 mutations lead to factor VIII binding defect and multimeric impairment . Blood . 2000;95:3139–3145
  50. Allen S , Abuzenadah AM , Blagg JL , Hinks J , Nesbitt IM , Goodeve AC , et al.   Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor . Blood . 2000;95:2000–2007
  51. Zhang ZP , Falk G , Blomback M , Egberg N , Anvret M . A single cytosine deletion in exon 18 of the von Willebrand factor gene is the most common mutation in Swedish vWD type III patients . Hum Mol Genet . 1992;1:767–768
  52. Schneppenheim R , Krey S , Bergmann F , Bock D , Budde U , Lange M , et al.   Genetic heterogeneity of severe von Willebrand disease type III in the German population . Hum Genet . 1994;94:640–652
  53. Gazda H , Budde U , Krey S , Rokicka-Milewska R , Schneppenheim R . Delta C in exon 18 of the von Willebrand factor gene is the most common mutation in patients with severe von Willebrand disease type 3 in Poland . Blood . 1997;90:3132; (abstr)
  54. Ruggeri ZM , Zimmerman TS . Variant von Willebrand’s disease (Characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets) . J Clin Invest . 1980;65:1318–1325
  55. Dent JA , Berkowitz SD , Ware J , Kasper CK , Ruggeri ZM . Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor . Proc Natl Acad Sci U S A . 1990;87:6306–63010
  56. Randi AM , Rabinowitz I , Mancuso DJ , Mannucci PM , Sadler JE . Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences . J Clin Invest . 1991;87:1220–1226
  57. Furlan M , Robles R , Lämmle B . Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis . Blood . 1996;87:4223–4234
  58. Tsai HM . Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion . Blood . 1996;87:4235–4244
  59. Enayat MS , Guilliatt AM , Surdhar GK , Jenkins PV , Pasi KJ , Toh CH , et al.   Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region (Identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease) . Blood . 2001;98:674–680
  60. Journet AM , Saffaripour S , Wagner DD . Requirement for both D domains of the propolypeptide in von Willebrand factor multimerization and storage . Thromb Haemost . 1993;70:1053–1057
  61. Eikenboom JC , Matsushita T , Reitsma PH , Tuley EA , Castaman G , Briet E , et al.   Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor . Blood . 1996;88:2433–2441
  62. Lethagen S , Isaksson C , Schaedel C , Holmberg L . Von Willebrand’s disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X) . Thromb Haemost . 2002;88:421–426
  63. Baronciani L , Cozzi G , Canciani MT , Peyvandi F , Srivastava A , Federici AB , et al.   Molecular defects in type 3 von Willebrand disease (Updated results from 40 multiethnic patients) . Blood Cells Mol Dis . 2003;30:264–270
  64. Dong Z , Thoma RS , Crimmins DL , McCourt DW , Tuley EA , Sadler JE . Disulfide bonds required to assemble functional von Willebrand factor multimers . J Biol Chem . 1994;269:6753–6758
  65. Holmberg L , Dent JA , Schneppenheim R , Budde U , Ware J , Ruggeri ZM . von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure . J Clin Invest . 1993;91:2169–2177
  66. Romijn RA , Westein E , Bouma B , Schiphorst ME , Sixma JJ , Lenting PJ , et al.   Mapping the collagen-binding site in the von Willebrand factor-A3 domain . J Biol Chem . 2003;278:15035–15039
  67. Hilbert L , Fressinaud E , Ribba AS , Meyer D , Mazurier C  INSERM Network on Molecular Abnormalities in von Willebrand Disease . Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor . Thromb Haemost . 2002;87:635–640
  68. Casonato A , Pontara E , Sartorello F , Bertomoro A , Durante C , Girolami A . Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization . J Lab Clin Med . 2001;137:70–76
  69. Hillery CA , Mancuso DJ , Sadler JE , Ponder JW , Jozwiak MA , Christopherson PA , et al.   Type 2M von Willebrand disease (F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets) . Blood . 1998;91:1572–1581
  70. Horellou MH , Baumelou E , Sitbon N , Marie JP , Conard J , De Carbonniere’s C , et al.   Quatre cas de deficit acquis en facteur Willebrand associés a une dysgubulinémie monoclonale . Ann Med Intern . 1983;143:707–712
  71. Moake JL . Thrombotic microangiopathies . N Engl J Med . 2002;347:589–600
  72. Nishio K , Anderson PJ , Zheng XL , Sadler JE . Binding of platelet glycoprotein Ib (α) to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13 . Proc Natl Acad Sci U S A . 2004;101:10578–10583
  73. Nitu-Whalley IC , Ridell A , Lee CA , Pasi KJ , Owens D , Enayat MS , et al.   Identifications of type 2 von Willebrand disease in previously diagnosed type 1 patients (A reappraisal using phenotypes, genotypes and molecular modelling) . Thromb Haemost . 2000;84:998–1004

PII: S0037-1963(04)00250-1

doi: 10.1053/j.seminhematol.2004.10.002

Seminars in Hematology
Volume 42, Issue 1 , Pages 15-28 , January 2005

Article Tools

* Image Usage & Resolution